Patents Assigned to BIOCAN LIMITED
  • Process for the Preparation of Insulin Conjugates
    Publication number: 20110020871
    Abstract: The invention claims a process for making an insulin-oligomer conjugate IN-105. IN-105 precursor having formula G-A-V-R-[B-Chain]-R-D-A-D-D-R-[A-Chain] is cloned and expressed in Pichia. The biosynthetic precursor is then conjugated with an activated oligomer. The IN-105 precursor-oligomer conjugate is then treated with protease and purified to afford active insulin-oligomer conjugate of formula insulin-OC—CH2—CH2—(OCH2CH2)3—OCH3.
    Type: Application
    Filed: October 13, 2005
    Publication date: January 27, 2011
    Applicant: BIOCAN LIMITED
    Inventors: Nitesh Dave, Partha Hazra, Anuj Goel, Nita Roy, Anand Khedkar, Harish Iyer, Gautam Krishnan, H.S. Manjunath, Shrikumar Suryanarayan, Govindasamy Manikam, Goldy Sachdev, Mayank Garg
  • Polymorphs of [R-(R*, R*) ]-2-(4-Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Magnesium Salt (2:1)
    Publication number: 20100168201
    Abstract: Crystalline and amorphous polymorphic forms of Atorvastatin magnesium and processes for their preparation are claimed.
    Type: Application
    Filed: November 29, 2005
    Publication date: July 1, 2010
    Applicant: BIOCAN LIMITED
    Inventors: Joy Mathew, Chandrashekar Aswathanarayanappa, Tom Thomas Puthiaparampil